Frédéric Tangy
36Patents
7h-index
51Co-inventors
68Inventor score
Filing activity: Dec 2, 2004 → Oct 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8343718B2 | Strain of SARS-associated coronavirus and applications thereof | Physics | 15 | Active |
| US7556812B2 | Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7736850B2 | Strain of SARS-associated coronavirus and applications thereof | Physics | 11 | Active |
| US8337857B2 | Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection | Emerging Cross-Sectional Technologies | 10 | Active |
| US8586364B2 | Cells and methodology to generate non-segmented negative-strand RNA viruses | Chemistry; Metallurgy | 10 | Active |
| US8853379B2 | Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection | Emerging Cross-Sectional Technologies | 8 | Active |
| US9005925B2 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions | Emerging Cross-Sectional Technologies | 7 | Active |
| US8859240B2 | Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications | Emerging Cross-Sectional Technologies | 7 | Active |
| US9012214B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 7 | Active |
| US9005961B2 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions | Emerging Cross-Sectional Technologies | 5 | Active |
| US9889193B2 | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy | Chemistry; Metallurgy | 2 | Active |
| US9023643B2 | Medicaments and methods for treating mesothelioma | Chemistry; Metallurgy | 2 | Active |
| US10316066B2 | Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US8980634B2 | Reverse genetics of negative-strand RNA viruses in yeast | Chemistry; Metallurgy | 2 | Active |
| US9701944B2 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions | Emerging Cross-Sectional Technologies | 2 | Active |
| US10793877B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9655961B2 | Recombinant measles virus expressing chikungunya virus polypeptides and their applications | Emerging Cross-Sectional Technologies | 1 | Active |
| US10314905B2 | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy | Chemistry; Metallurgy | 1 | Active |
| US10519466B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9914937B2 | Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9315482B2 | Derivatives useful as antiviral agents | Chemistry; Metallurgy | 0 | Active |
| US11020473B2 | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US9682136B2 | Reverse genetics of negative-strand RNA viruses in yeast | Chemistry; Metallurgy | 0 | Active |
| US9499799B2 | Cells and methodology to generate non-segmented negative-strand RNA viruses | Chemistry; Metallurgy | 0 | Active |
| US9579375B2 | Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.